首页> 外文期刊>JAMA: the Journal of the American Medical Association >Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.
【24h】

Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.

机译:感染性心内膜炎并发心力衰竭患者的瓣膜手术与死亡率之间的关联。

获取原文
获取原文并翻译 | 示例
       

摘要

CONTEXT: Heart failure (HF) is the most common complication of infective endocarditis. However, clinical characteristics of HF in patients with infective endocarditis, use of surgical therapy, and their associations with patient outcome are not well described. OBJECTIVES: To determine the clinical, echocardiographic, and microbiological variables associated with HF in patients with definite infective endocarditis and to examine variables independently associated with in-hospital and 1-year mortality for patients with infective endocarditis and HF, including the use and association of surgery with outcome. DESIGN, SETTING, AND PATIENTS: The International Collaboration on Endocarditis-Prospective Cohort Study, a prospective, multicenter study enrolling 4166 patients with definite native- or prosthetic-valve infective endocarditis from 61 centers in 28 countries between June 2000 and December 2006. MAIN OUTCOME MEASURES: In-hospital and 1-year mortality. RESULTS: Of 4075 patients with infective endocarditis and known HF status enrolled, 1359 (33.4% [95% CI, 31.9%-34.8%]) had HF, and 906 (66.7% [95% CI, 64.2%-69.2%]) were classified as having New York Heart Association class III or IV symptom status. Within the subset with HF, 839 (61.7% [95% CI, 59.2%-64.3%]) underwent valvular surgery during the index hospitalization. In-hospital mortality was 29.7% (95% CI, 27.2%-32.1%) for the entire HF cohort, with lower mortality observed in patients undergoing valvular surgery compared with medical therapy alone (20.6% [95% CI, 17.9%-23.4%] vs 44.8% [95% CI, 40.4%-49.0%], respectively; P < .001). One-year mortality was 29.1% (95% CI, 26.0%-32.2%) in patients undergoing valvular surgery vs 58.4% (95% CI, 54.1%-62.6%) in those not undergoing surgery (P < .001). Cox proportional hazards modeling with propensity score adjustment for surgery showed that advanced age, diabetes mellitus, health care-associated infection, causative microorganism (Staphylococcus aureus or fungi), severe HF (New York Heart Association class III or IV), stroke, and paravalvular complications were independently associated with 1-year mortality, whereas valvular surgery during the initial hospitalization was associated with lower mortality. CONCLUSION: In this cohort of patients with infective endocarditis complicated by HF, severity of HF was strongly associated with surgical therapy and subsequent mortality, whereas valvular surgery was associated with lower in-hospital and 1-year mortality.
机译:背景:心力衰竭(HF)是感染性心内膜炎的最常见并发症。但是,对于感染性心内膜炎患者心力衰竭的临床特征,手术治疗的使用以及它们与患者预后的关系并没有得到很好的描述。目的:确定感染性心内膜炎患者中与心衰相关的临床,超声心动图和微生物学变量,并检查感染性心内膜炎和心衰患者与院内死亡率和1年死亡率独立相关的变量,包括使用和相关性有结局的手术。设计,地点和患者:心内膜炎前瞻性队列研究国际合作研究是一项前瞻性,多中心研究,从2000年6月至2006年12月,来自28个国家/地区的61个中心的4166例患有确定性自然或人工瓣膜感染性心内膜炎的患者入组。措施:住院和1年死亡率。结果:在4075例感染性心内膜炎且已知HF状态的患者中,有1359例(33.4%[95%CI,31.9%-34.8%])和906例(66.7%[95%CI,64.2%-69.2%])被归类为纽约心脏协会的III级或IV级症状状态。在心衰患者中,839名(61.7%[95%CI,59.2%-64.3%])在指数住院期间接受了瓣膜手术。整个HF队列的院内死亡率为29.7%(95%CI,27.2%-32.1%),与单纯药物治疗相比,接受瓣膜手术的患者死亡率更低(20.6%[95%CI,17.9%-23.4] %]对比44.8%[95%CI,40.4%-49.0%]; P <.001)。瓣膜手术患者的一年死亡率为29.1%(95%CI,26.0%-32.2%),而未接受瓣膜手术的患者为58.4%(95%CI,54.1%-62.6%)(P <.001)。 Cox比例风险建模和手术倾向评分调整显示,高龄,糖尿病,医疗相关感染,病原微生物(金黄色葡萄球菌或真菌),严重HF(纽约心脏协会III级或IV级),中风和瓣周并发症与1年死亡率独立相关,而在初始住院期间进行瓣膜手术与降低死亡率相关。结论:在这一人群合并感染性心内膜炎并发心力衰竭的病例中,心力衰竭的严重程度与手术治疗和随后的死亡率密切相关,而瓣膜手术与住院时间和1年死亡率较低有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号